NeurogesX Brings Astellas On Board To Launch Pain Patch in Europe
This article was originally published in PharmAsia News
Executive Summary
A deal with Astellas to market and distribute the neuropathic pain patch Qutenza in Europe will bolster NeurogesX's cash position, giving the company some breathing room to prepare for regulatory approval and a 2010 launch in the U.S. market